Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by NautaDutilh ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Court Of Appeal Of The Hague: One SPC Per Patent
On 27 August 2013, the Court of Appeal of The Hague rendered a remarkable judgment in preliminary injunction proceedings between Teva and Sanofi.
Netherlands
8 Oct 2013
2
Ambitious Reform Of The Medical Devices Regulatory Framework
The medical devices sector covers a wide range of products, from simple bandages to highly sophisticated devices such as pacemakers, as well as contact lenses, prostheses, medical equipment for hospital use, etc.
Belgium
10 Jan 2013
3
AstraZeneca - CJEU's Decision Re. Abuse Of Dominant Position (Losec)
In a judgment of 6 December 2012, the Court of Justice dismissed AstraZeneca's appeal against the General Court's decision that the company had abused its dominant position with respect to its blockbuster anti-ulcer drug, Losec.
Netherlands
21 Dec 2012
4
Healthcare Policy Meets Patent Law: Preferential Treatment Of Generics While The Originator Has Patent Protection
The Court of Appeals of The Hague has recently ruled that healthcare insurance companies, by inviting parties to bid in a tender to become the preferred supplier of a medicinal product which is still under patent protection, do not infringe the originator's patent and do not commit an "unlawful act".
Netherlands
27 Sep 2012
5
Dutch Cabinet Submits Draft Act On Sector-Specific Healthcare Merger Control
On 10 May, Edith Schippers, the Health Secretary in the Dutch Rutte I Government, which tendered its resignation at the beginning of the month, submitted a Draft Act on Continuity, Mergers and Divestments in the Healthcare Sector to the Dutch Lower House.
Netherlands
28 May 2012
6
Nautadutilh And Niaba Publish Report On Market Developments In The Dutch Biotechnology Industry
NautaDutilh and the Netherlands Biotech Industry Association (Niaba) are pleased to inform you that we have published our report on market expectations in the Dutch biotechnology industry.
Netherlands
22 May 2012
7
Stem Cell Patents In The EU: To Be Or Not To Be?
The patent of Oliver Brüstle that is at stake relates to purified neural precursor cells and to processes for their production from embryonic stem cells.
Netherlands
20 Oct 2011
8
EU Court Advisor Positive On Negative SPC Term Extension
Merck Sharp & Dohme (MSD) is the owner of a European patent for a medicinal product containing the compound sitagliptine. The application for this patent was filed on 5 July 2002.
Netherlands
15 Jun 2011
Links to Result pages
 
1